| Bioactivity | 4-(Benzo[d]oxazol-2-yl)aniline is a potent antitumor agent. 4-(Benzo[d]oxazol-2-yl)aniline has inhibitory activity against mammary carcinoma cell lines[1]. |
| Invitro | 4-(Benzo[d]oxazol-2-yl)aniline (compound 5b) (0-100 μM; 7 days for MCF-7 and 10 days for MDA 468) has inhibitory activity against MCF-7 and MDA 468 mammary carcinoma cell lines[1]. Cell Proliferation Assay[1] Cell Line: |
| Name | 4-(Benzo[d]oxazol-2-yl)aniline |
| CAS | 20934-81-0 |
| Formula | C13H10N2O |
| Molar Mass | 210.23 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Shi DF, et al. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem. 1996 Aug 16;39(17):3375-84. |
4-(Benzo[d]oxazol-2-yl)aniline
CAS: 20934-81-0 F: C13H10N2O W: 210.23
4-(Benzooxazol-2-yl)aniline is a potent antitumor agent. 4-(Benzooxazol-2-yl)aniline has inhibitory activity against mam
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.